Search Results

You are looking at 1 - 10 of 41 items for

  • Author or Editor: Mark Payton x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To compare the effects of meloxicam, carprofen, and flunixin meglumine administered IV on the concentration of prostaglandin E2 (PGE2) in the aqueous humor of dogs with aqueocentesis-induced anterior uveitis.

Animals—15 adult dogs with ophthalmically normal eyes.

Procedures—Each dog was assigned to 1 of 4 treatment groups. Treatment groups were saline (0.9% NaCl) solution (1 mL, IV), meloxicam (0.2 mg/kg, IV), carprofen (4.4 mg/kg, IV), and flunixin meglumine (0.5 mg/kg, IV). Each dog was anesthetized, treatment was administered, and aqueocentesis was performed on each eye at 30 and 60 minutes after treatment. Aqueous humor samples were frozen at −80°C until assayed for PGE2 concentration with an enzyme immunoassay kit.

Results—For all 4 treatment groups, PGE2 concentration was significantly higher in samples obtained 60 minutes after treatment, compared with that in samples obtained 30 minutes after treatment, which indicated aqueocentesis-induced PGE2 synthesis. For aqueous humor samples obtained 60 minutes after treatment, PGE2 concentration did not differ significantly among groups treated with saline solution, meloxicam, and carprofen; however, the PGE2 concentration for the group treated with flunixin meglumine was significantly lower than that for each of the other 3 treatment groups.

Conclusions and Clinical Relevance—Flunixin meglumine was more effective than meloxicam or carprofen for minimizing the PGE2 concentration in the aqueous humor of dogs with experimentally induced uveitis. Flunixin meglumine may be an appropriate pre-medication for use prior to intraocular surgery in dogs.

Full access
in American Journal of Veterinary Research

Abstract

Objective—To biomechanically evaluate various finger trap patterns and suture materials for securing 5F polyvinylchloride and polypropylene catheters.

Design—In vitro prospective study.

Sample—132 finger trap constructs.

Procedures—Each group of constructs comprised 6 to 10 replicates each of 3 finger trap patterns tied with 2–0 glycolide-lactide copolymer (GLC), braided nylon, and monofilament polypropylene suture on 5F polypropylene and polyvinylchloride catheters. The 3 finger trap variants were of similar lengths but differed in the number of surgeon's throws included in the pattern. Constructs were tested with a universal materials testing machine to the point of failure or a maximum of 100 mm of distraction. Force and distraction data were evaluated for significance with a competing risks model.

Results—There was no difference in performance (as measured by the proportion of test failures, median distraction distance, or median force at failure or end of testing) attributable to the finger trap pattern variants. Sixteen of 66 constructs with polyvinylchloride catheter material failed at ≤ 100 mm distraction, whereas all polypropylene constructs failed during testing. For polypropylene catheters, braided nylon or GLC suture withstood greater distraction distance and force, respectively. For polyvinylchloride catheters, differences among suture types were nonsignificant.

Conclusions and Clinical Relevance—Data suggested that, for the material combinations evaluated, a finger trap suture pattern with fewer knots may provide catheter security similar to that for patterns tied with a more traditional pattern. These results should not be extrapolated to catheters of different diameters or materials, patterns tied with different suture sizes, or clinical performance in vivo without further testing.

Restricted access
in Journal of the American Veterinary Medical Association

Abstract

OBJECTIVE To evaluate the effect of brachycephaly and body condition score on respiratory thermoregulation of healthy dogs.

DESIGN Prospective study.

ANIMALS 52 brachycephalic and 53 nonbrachycephalic dogs.

PROCEDURES All dogs were exposed to a cool treatment (temperature, 21.8 ± 1.7°C [71.2 ± 3.1°F]; relative humidity, 62.2 ± 9.7%; and ambient enthalpy, 47.7 ± 6.6 kcal/kg) and then a hot treatment (temperature, 32.9 ± 1.7°C [91.2 ± 3.1°F]; relative humidity, 51.9 ± 9.8%; and ambient enthalpy, 74.8 ± 8.7 kcal/kg; heat stress) at least 1 hour later. For each treatment, dogs were allowed to acclimatize to the environment for 15 minutes and then were placed in a sealed whole-body plethysmograph for continuous measurement of the respiratory pattern for 10 minutes. Treatment was discontinued if a dog developed signs of respiratory distress. Respiratory variables and body temperature were compared between the 2 breed types (brachycephalic and nonbrachycephalic) and between treatments.

RESULTS Body condition score was positively associated with body temperature independent of environmental conditions or breed type and negatively associated with tidal volume. Brachycephalic dogs had a greater increase in respiratory rate in response to heat stress than did nonbrachycephalic dogs.

CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that brachycephalic dogs had decreased capacity for thermoregulation, compared with nonbrachycephalic dogs, but body condition score was a greater determinant of body temperature than breed type. Nevertheless, both upper airway conformation and body condition score should be considered when evaluating whether an individual dog is capable of tolerating heat stress.

Restricted access
in Journal of the American Veterinary Medical Association

Abstract

Objective—To establish reference ranges for indices of urine N-acetyl-B-D-glucosaminidase (NAG) and G-glutamyl transpeptidase (GGT) activities in clinically normal adult dogs.

Animals—38 dogs.

Procedures—Each dog underwent a physical examination, CBC, serum biochemical analysis, urinalysis, and serologic testing for heartworm antigen and antibodies against Ehrlichia canis and Borrelia burgdorferi. Activities of NAG and GGT in urine were evaluated, and values of the respective indices were determined as urine NAG or GGT activity (U/L) divided by urine creatinine concentration (g/L).

Results—All dogs were considered clinically normal. A 90% prediction interval based on the 5th and 95th percentiles for GGT and NAG index values from both sexes was used to establish the reference ranges for dogs: 1.93 to 28.57 U/g and 0.02 to 3.63 U/g, respectively. Between males and females, urine NAG index differed significantly, whereas urine GGT index did not. When accounting for sex differences, reference ranges for the urine NAG index in males and females were 0.02 to 3.65 U/g and 0.02 to 2.31 U/g, respectively. Changes in urine pH significantly affected the urine GGT index but not the urine NAG index. Neither index changed significantly with changes in body surface area.

Conclusions and Clinical Relevance—Data suggest that increases in urine NAG and GGT indices allow for earlier detection of renal tubular damage in dogs. Such early detection would enable adjustment of the clinical management of affected dogs to decrease morbidity and death rates associated with acute tubular injury and acute tubular necrosis.

Full access
in American Journal of Veterinary Research

Abstract

OBJECTIVE To determine rate of recurrence of disk herniation in dogs that underwent percutaneous laser disk ablation (PLDA) because of a previous episode of suspected or confirmed thoracolumbar intervertebral disk herniation (IVDH).

DESIGN Retrospective case series.

ANIMALS 303 dogs that underwent PLDA and for which a minimum of 3 years of follow-up information was available (n = 294) or for which recurrence was documented within 3 years after the procedure (9).

PROCEDURES Information on signalment, previous episodes of IVDH, specifics of the PLDA procedure, and recurrence was obtained from the medical records. Owners were contacted to complete a questionnaire regarding outcome and recurrence.

RESULTS 60 of the 303 (19.8%) dogs had an episode of suspected or confirmed IVDH after undergoing PLDA, but only 11 of the 303 (3.6%) dogs had a recurrence of IVDH confirmed by means of CT or MRI and hemilaminectomy. Recurrence rate following PLDA was not significantly different between dogs that had been treated medically for previous episodes of IVDH and dogs that had been treated surgically. Overall, 270 of 286 (94.4%) owners reported that their dog was the same (109 [38.1%]) or improved (161 [56.3%]) immediately after PLDA, and 265 (92.7%) owners rated their satisfaction with the procedure as ≥ 9 on a scale from 1 (completely dissatisfied) to 10 (completely satisfied).

CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that PLDA was a relatively safe, minimally invasive procedure associated with a low rate of recurrence of disk herniation when performed in dogs with a history of previous episodes of suspected or confirmed IVDH.

Restricted access
in Journal of the American Veterinary Medical Association

Abstract

Objective—To assess gait abnormalities associated with selective anesthesia of the suprascapular nerve (SSN) achieved by use of perineural catheterization and thereby determine the function of that nerve as it relates to gait in horses.

Animals—3 adult horses with no preexisting clinically apparent lameness at a walk.

Procedure—Each horse was anesthetized; the right SSN was exposed surgically for placement of a perineural catheter to permit delivery of 1 mL of 2% mepivacaine hydrochloride. Six hours after recovery from anesthesia, each horse was videotaped while walking (50-step data acquisition period) before and after administration of mepivacaine. Videotapes were reviewed and the proportion of abnormal steps before and after selective SSN anesthesia was assessed. A step was considered abnormal if a marked amount of scapulohumeral joint instability (ie, lateral luxation of the proximal portion of the humerus) was observed during the weight-bearing phase of the stride.

Results—Clinically apparent gait dysfunction was detected in all 3 horses following perineural administration of the local anesthetic agent. Anesthesia of the SSN resulted in scapulohumeral joint instability as evidenced by consistent lateral excursion of the shoulder region during the weight-bearing phase of gait at a walk. The proportion of abnormal steps before and after SSN anesthesia was significantly different in all 3 horses.

Conclusions and Clinical Relevance—These data support the role of the SSN in shoulder joint stability in horses and define SSN dysfunction as 1 mechanism by which the syndrome and gait dysfunction clinically referred to as sweeny may develop.

Full access
in American Journal of Veterinary Research

Abstract

Objective—To evaluate the musculoskeletal analgesic effect of etodolac administered PO every 12 or 24 hours in chronically lame horses by use of force plate analysis.

Animals—22 horses with navicular syndrome.

Procedure—Horses received etodolac (23 mg/kg, PO, q 12 h; n = 7), etodolac (23 mg/kg, PO, q 24 h; 8), or corn syrup (20 mL, PO, q 24 h; control treatment; 7) for 3 days. Combined forelimb peak vertical ground reaction force (PVF) was measured via force plate analysis before the first treatment (baseline) and at 6, 12, 24, and 36 hours after the last treatment. Differences in mean PVF (mPVF) between baseline and subsequent measurements were analyzed (repeated-measures ANOVA) and evaluated for treatment and time effects and treatment-time interaction.

Results—Once- or twice-daily administration of etodolac resulted in significant increases in mPVF from baseline at 6, 12, and 24 hours after the last treatment, compared with the control treatment. There were no significant differences in mPVF between the etodolac treatment groups at any time point. In both etodolac treatment groups, there was a significant increase in mPVF from baseline at 6, 12, and 24 hours, compared with that at 36 hours. Etodolac-associated adverse effects were not detected.

Conclusions and Clinical Relevance—In horses with navicular syndrome, once-daily oral administration of 23 mg of etodolac/kg appears to provide effective analgesia for as long as 24 hours. Twice-daily administration of etodolac at this same dose does not appear to provide any additional analgesic efficacy or duration of effect.

Full access
in American Journal of Veterinary Research

Abstract

Case Description—8 dogs that underwent carbon dioxide (CO2) laser ablation of transitional cell carcinoma in the bladder trigone and proximal portion of the urethra and were also treated with mitotranxone and piroxicam.

Clinical Findings—Transitional cell carcinoma of the bladder frequently involves the trigone and urethra and can be difficult to manage surgically. Dogs underwent laser ablation of the primary tumor and were treated with mitoxantrone at a dosage of 5 mg/m2 every 3 weeks for 4 treatments. Piroxicam was given at a dosage of 0.3 mg/kg (0.14 mg/lb) once daily for the remaining life of the dog.

Treatment and Outcome—Median and mean disease-free intervals were 200 and 280 days, respectively. Median and mean survival times were 299 and 411 days, respectively. Adverse treatment effects were observed in 2 dogs; signs included mild, self-limiting inappetance and lethargy. The procedure appeared to be well tolerated; all treated dogs had rapid resolution of clinical signs of disease of the lower portion of the urinary tract.

Clinical Relevance—Although survival times achieved with CO2 laser ablation and treatment with mitoxantrone and piroxicam were similar to survival times associated with chemotherapy alone, resolution of clinical signs was better with the combined treatment.

Restricted access
in Journal of the American Veterinary Medical Association

Abstract

Objective—To compare the effects of hetastarch and lactated Ringer's solution (LRS) on plasma colloid osmotic pressure (pCOP) and other hematologic variables in healthy llamas.

Design—Prospective crossover study.

Animals—6 healthy female llamas.

Procedures—Llamas were administered LRS (45 mL/kg [20.5 mL/lb]) and, after a 3-day washout period, hetastarch (15 mL/kg [6.8 mL/lb]) during 60-minute IV infusions. Serum total protein, serum albumin, and hemoglobin concentrations and Hct were measured before each infusion (baseline), immediately after each infusion was completed (0 hours), and at 2, 4, 8, and 12 hours. The pCOP was measured at baseline and at 0, 2, 4, 8, 12, 24, 36, and 48 hours after each infusion was completed; additional measurements of pCOP were obtained 72 and 96 hours after hetastarch infusion.

Results—Hetastarch administration significantly increased mean ± SEM pCOP from 23.5 ± 0.3 mm Hg (baseline) to a peak of 28.4 ± 0.6 mm Hg (12 hours); significant increases in pCOP persisted at 96 hours after hetastarch administration. Administration of LRS significantly decreased albumin and total protein concentrations; in addition, mean ± SEM pCOP decreased from 24.1 ± 0.4 mm Hg (baseline) to 18.0 ± 0.3 mm Hg (0 hours). Hetastarch administration caused more pronounced decreases in Hct (0 hours) and concentrations of hemoglobin (0 hours), albumin (all time points), and total protein (all time points) than did LRS administration.

Conclusions and Clinical Relevance—Hetastarch administration increased pCOP in healthy llamas for 96 hours with no clinically important complications.

Restricted access
in Journal of the American Veterinary Medical Association

Abstract

OBJECTIVE To determine the clinical manifestations of histoplasmosis in a large sample of dogs, compare outcomes achieved with fluconazole versus itraconazole, and identify variables available at the time of diagnosis with prognostic value.

DESIGN Retrospective case series with nested cohort study.

ANIMALS 79 dogs with confirmed histoplasmosis evaluated at 2 veterinary teaching hospitals from 1999 through 2015.

PROCEDURES Medical records were reviewed and data extracted regarding clinical signs at evaluation, physical examination findings, clinical laboratory values, other diagnostic test results, treatments, and outcomes. Data were compared between antifungal agents used (fluconazole or itraconazole) and between other variables.

RESULTS Various breeds were represented. Working and herding breeds had mostly disseminated histoplasmosis, and toy breeds had mostly the gastrointestinal form. The diagnosis was often achieved with noninvasive techniques, such as cytologic evaluation of rectal scrape samples (n = 24) or blood films (15). Clinical remission was achieved in 16 of 25 (64%) dogs receiving fluconazole and 17 of 24 (71%) dogs receiving itraconazole. No differences were identified between antifungal agents in survival, clinical remission, or disease relapse rates. Identified negative prognostic factors included Great Pyrenees breed, dyspnea, need for oxygen supplementation, icterus, palpable abdominal organomegaly, anemia, thrombocytopenia, hypercalcemia, high serum alkaline phosphatase activity, and hyperbilirubinemia, whereas diarrhea was a positive prognostic factor.

CONCLUSIONS AND CLINICAL RELEVANCE Findings suggested that histoplasmosis should be considered in a sick dog of any breed in an endemic area. Clinical signs may be nonspecific. Diagnosis may often be possible with noninvasive and inexpensive tests. Either fluconazole or itraconazole may be an effective treatment option.

Restricted access
in Journal of the American Veterinary Medical Association